Selected research
Industry Research
Concentrated Angelica Pills Industry Research Report 2026
Market perspective
The global Concentrated Angelica Pills market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Concentrated Angelica Pills is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Concentrated Angelica Pills is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Concentrated Angelica Pills is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Concentrated Angelica Pills include BAOSHANG GROUP, Beijing Hygeia Medical Technique, BEIJING TONG REN TANG, Gansu Hexi Pharmaceutical, Gansu Minzhou Industrial Group, Gansu Pharmaceutical Group, Guangdong Fengchun Pharmaceutical, Lanzhou Foci Pharmaceutical and Zhongjing Wanxi Pharmacentical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Concentrated Angelica Pills market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Concentrated Angelica Pills Market by Company
BAOSHANG GROUP
Beijing Hygeia Medical Technique
BEIJING TONG REN TANG
Gansu Hexi Pharmaceutical
Gansu Minzhou Industrial Group
Gansu Pharmaceutical Group
Guangdong Fengchun Pharmaceutical
Lanzhou Foci Pharmaceutical
Zhongjing Wanxi Pharmacentical
Concentrated Angelica Pills Segment by Type
Eastern Danggui
European Danggui
Concentrated Angelica Pills Segment by Application
Hospital
Clinic
Pharmacy
Concentrated Angelica Pills Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Concentrated Angelica Pills market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Concentrated Angelica Pills and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Concentrated Angelica Pills.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Concentrated Angelica Pills manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Concentrated Angelica Pills by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Concentrated Angelica Pills in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Eastern Danggui
- European Danggui
Applications
- Hospital
- Clinic
- Pharmacy
Companies covered
- BAOSHANG GROUP
- Beijing Hygeia Medical Technique
- BEIJING TONG REN TANG
- Gansu Hexi Pharmaceutical
- Gansu Minzhou Industrial Group
- Gansu Pharmaceutical Group
- Guangdong Fengchun Pharmaceutical
- Lanzhou Foci Pharmaceutical
- Zhongjing Wanxi Pharmacentical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Concentrated Angelica Pills Market Size (2021-2032)
- 2.2.2 Global Concentrated Angelica Pills Sales (2021-2032)
- 2.2.3 Global Concentrated Angelica Pills Market Average Price (2021-2032)
- 2.3 Concentrated Angelica Pills by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Eastern Danggui
- 2.3.3 European Danggui
- 2.4 Concentrated Angelica Pills by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Concentrated Angelica Pills Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Concentrated Angelica Pills Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Concentrated Angelica Pills Revenue of Manufacturers (2021-2026)
- 3.4 Global Concentrated Angelica Pills Average Price by Manufacturers (2021-2026)
- 3.5 Global Concentrated Angelica Pills Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Concentrated Angelica Pills, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Concentrated Angelica Pills, Product Type & Application
- 3.8 Global Manufacturers of Concentrated Angelica Pills, Established Date
- 3.9 Global Concentrated Angelica Pills Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 BAOSHANG GROUP
- 4.1.1 BAOSHANG GROUP Company Information
- 4.1.2 BAOSHANG GROUP Business Overview
- 4.1.3 BAOSHANG GROUP Concentrated Angelica Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 BAOSHANG GROUP Concentrated Angelica Pills Product Portfolio
- 4.1.5 BAOSHANG GROUP Recent Developments
- 4.2 Beijing Hygeia Medical Technique
- 4.2.1 Beijing Hygeia Medical Technique Company Information
- 4.2.2 Beijing Hygeia Medical Technique Business Overview
- 4.2.3 Beijing Hygeia Medical Technique Concentrated Angelica Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Beijing Hygeia Medical Technique Concentrated Angelica Pills Product Portfolio
- 4.2.5 Beijing Hygeia Medical Technique Recent Developments
- 4.3 BEIJING TONG REN TANG
- 4.3.1 BEIJING TONG REN TANG Company Information
- 4.3.2 BEIJING TONG REN TANG Business Overview
- 4.3.3 BEIJING TONG REN TANG Concentrated Angelica Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 BEIJING TONG REN TANG Concentrated Angelica Pills Product Portfolio
- 4.3.5 BEIJING TONG REN TANG Recent Developments
- 4.4 Gansu Hexi Pharmaceutical
- 4.4.1 Gansu Hexi Pharmaceutical Company Information
- 4.4.2 Gansu Hexi Pharmaceutical Business Overview
- 4.4.3 Gansu Hexi Pharmaceutical Concentrated Angelica Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Gansu Hexi Pharmaceutical Concentrated Angelica Pills Product Portfolio
- 4.4.5 Gansu Hexi Pharmaceutical Recent Developments
- 4.5 Gansu Minzhou Industrial Group
- 4.5.1 Gansu Minzhou Industrial Group Company Information
- 4.5.2 Gansu Minzhou Industrial Group Business Overview
- 4.5.3 Gansu Minzhou Industrial Group Concentrated Angelica Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Gansu Minzhou Industrial Group Concentrated Angelica Pills Product Portfolio
- 4.5.5 Gansu Minzhou Industrial Group Recent Developments
- 4.6 Gansu Pharmaceutical Group
- 4.6.1 Gansu Pharmaceutical Group Company Information
- 4.6.2 Gansu Pharmaceutical Group Business Overview
- 4.6.3 Gansu Pharmaceutical Group Concentrated Angelica Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Gansu Pharmaceutical Group Concentrated Angelica Pills Product Portfolio
- 4.6.5 Gansu Pharmaceutical Group Recent Developments
- 4.7 Guangdong Fengchun Pharmaceutical
- 4.7.1 Guangdong Fengchun Pharmaceutical Company Information
- 4.7.2 Guangdong Fengchun Pharmaceutical Business Overview
- 4.7.3 Guangdong Fengchun Pharmaceutical Concentrated Angelica Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Guangdong Fengchun Pharmaceutical Concentrated Angelica Pills Product Portfolio
- 4.7.5 Guangdong Fengchun Pharmaceutical Recent Developments
- 4.8 Lanzhou Foci Pharmaceutical
- 4.8.1 Lanzhou Foci Pharmaceutical Company Information
- 4.8.2 Lanzhou Foci Pharmaceutical Business Overview
- 4.8.3 Lanzhou Foci Pharmaceutical Concentrated Angelica Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Lanzhou Foci Pharmaceutical Concentrated Angelica Pills Product Portfolio
- 4.8.5 Lanzhou Foci Pharmaceutical Recent Developments
- 4.9 Zhongjing Wanxi Pharmacentical
- 4.9.1 Zhongjing Wanxi Pharmacentical Company Information
- 4.9.2 Zhongjing Wanxi Pharmacentical Business Overview
- 4.9.3 Zhongjing Wanxi Pharmacentical Concentrated Angelica Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Zhongjing Wanxi Pharmacentical Concentrated Angelica Pills Product Portfolio
- 4.9.5 Zhongjing Wanxi Pharmacentical Recent Developments
5 Global Concentrated Angelica Pills Market Scenario by Region
- 5.1 Global Concentrated Angelica Pills Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Concentrated Angelica Pills Sales by Region: 2021-2032
- 5.2.1 Global Concentrated Angelica Pills Sales by Region: 2021-2026
- 5.2.2 Global Concentrated Angelica Pills Sales by Region: 2027-2032
- 5.3 Global Concentrated Angelica Pills Revenue by Region: 2021-2032
- 5.3.1 Global Concentrated Angelica Pills Revenue by Region: 2021-2026
- 5.3.2 Global Concentrated Angelica Pills Revenue by Region: 2027-2032
- 5.4 North America Concentrated Angelica Pills Market Facts & Figures by Country
- 5.4.1 North America Concentrated Angelica Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Concentrated Angelica Pills Sales by Country (2021-2032)
- 5.4.3 North America Concentrated Angelica Pills Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Concentrated Angelica Pills Market Facts & Figures by Country
- 5.5.1 Europe Concentrated Angelica Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Concentrated Angelica Pills Sales by Country (2021-2032)
- 5.5.3 Europe Concentrated Angelica Pills Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Concentrated Angelica Pills Market Facts & Figures by Country
- 5.6.1 Asia Pacific Concentrated Angelica Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Concentrated Angelica Pills Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Concentrated Angelica Pills Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Concentrated Angelica Pills Market Facts & Figures by Country
- 5.7.1 South America Concentrated Angelica Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Concentrated Angelica Pills Sales by Country (2021-2032)
- 5.7.3 South America Concentrated Angelica Pills Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Concentrated Angelica Pills Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Concentrated Angelica Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Concentrated Angelica Pills Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Concentrated Angelica Pills Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Concentrated Angelica Pills Sales by Type (2021-2032)
- 6.1.1 Global Concentrated Angelica Pills Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Concentrated Angelica Pills Sales Market Share by Type (2021-2032)
- 6.2 Global Concentrated Angelica Pills Revenue by Type (2021-2032)
- 6.2.1 Global Concentrated Angelica Pills Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Concentrated Angelica Pills Revenue Market Share by Type (2021-2032)
- 6.3 Global Concentrated Angelica Pills Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Concentrated Angelica Pills Sales by Application (2021-2032)
- 7.1.1 Global Concentrated Angelica Pills Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Concentrated Angelica Pills Sales Market Share by Application (2021-2032)
- 7.2 Global Concentrated Angelica Pills Revenue by Application (2021-2032)
- 7.2.1 Global Concentrated Angelica Pills Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Concentrated Angelica Pills Revenue Market Share by Application (2021-2032)
- 7.3 Global Concentrated Angelica Pills Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Concentrated Angelica Pills Value Chain Analysis
- 8.1.1 Concentrated Angelica Pills Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Concentrated Angelica Pills Production Mode & Process
- 8.2 Concentrated Angelica Pills Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Concentrated Angelica Pills Distributors
- 8.2.3 Concentrated Angelica Pills Customers
9 Global Concentrated Angelica Pills Analyzing Market Dynamics
- 9.1 Concentrated Angelica Pills Industry Trends
- 9.2 Concentrated Angelica Pills Industry Drivers
- 9.3 Concentrated Angelica Pills Industry Opportunities and Challenges
- 9.4 Concentrated Angelica Pills Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst